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Summary 
T-B cell interactions have a central role in the development of antibody responses. Upon activation, 
T helper (Th) cells express the ligand for CD40, gp39, which is essential for Th cell-dependent 
B cell activation. The cytokines produced by activated Th cells have a regulatory role in B cell 
differentiation. In this study, we investigated, using immunohistochemical techniques, the in 
vivo time course and localization of gp39 expression and cytokine production in relation to the 
specific antibody production. Both the immunization with keyhole limpet hemocyanin (KLH), 
a thymus-dependent (TD) antigen, and trinitrophenyl (TNP)-FicoU, a thymus-independent type 
2 (TI-2) antigen, induced Th cells to express gp39. The expression of gp39 was restricted to 
Th cells in the outer periarteriolar lymphocyte sheaths  (outer-PALS)  and around the terminal 
arterioles (TA). Incidentally, gp39 + Th cells were found in the corona of follicles, whereas gp39 + 
cells were never found in the germinal centers or marginal zones of the spleen. Maximum frequencies 
of gp39 + cells were observed 3 and 4 d after primary and secondary immunization with KLH. 
After injection of TNP-Ficoll,  a  marked increase  in gp39 + cells was  observed,  confirming 
previous observations that activated  T  cells are involved in TI-2 antibody responses.  Analysis 
of the in vivo cytokine production revealed that interleukin 2 (IL-2)-,  IL-4- and interferon 3/ 
(IFN-q0-producing cells (IFN-q/-PC)  developed according to similar  kinetics as observed for 
gp39 + cells. IL-2-PC and IL-4-PC were present in higher frequencies as were IFN-3/-PC in the 
immune response against TNP-KLH.  Double staining experiments revealed gp39 + Th cells 
producing IL-2, IL-4,  or IFN-%  suggesting that these cells were involved in both the initial 
activation as well as the differentiation process  of B cells into antibody-forming cells. Dual 
immunohistochemical analysis revealed gp39 + T  cells and cytokine-PC in close proximity to 
antigen-specific,  antibody-forming B cells. In conclusion, this study shows that in vivo gp39 is 
expressed on activated Th cells after immunization with TD and TI-2 antigens. Furthermore, 
the time course and compartmentalization of gp39 + expression,  cytokine production and anti- 
body formation after immunization suggest that cognate T-B cell interactions and T cell-regnlated 
B cell differentiation occur in the outer-PALS and around the TA of the spleen. 
T 
he initiation of thymus-dependent (TD) I antibody re- 
sponses requires cognate interactions of class II-restricted, 
1 Abbreviations used in this paper: AEC, ethylcarbazole; AFC, antibody- 
forming  cell; AP,  alkaline phosphatase; GC,  germinal  center; HRP, 
horseradish peroxidase; PALS, outer periarteriolar lymphocyte sheath; PC, 
producing cell; TA, terminal arteriole; TD, thymus dependent; TI-2, thymus 
independent. 
antigen-specific  Th cells with B cells. None of the molecu- 
larly cloned cytokines, alone or in combination, can replace 
the contact-dependent requirement for B cell activation (1-3). 
The molecule that mediates the contact-dependent signal was 
identified as a membrane protein that is expressed on the sur- 
face of activated Th cells (4, 5). This membrane protein, gp39, 
was identified as the ligand for the B cell membrane protein 
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from activated Th cells showed that these plasma membranes 
induce the activation of resting B cells (6, 7). A soluble, CD40- 
Ig fusion protein and a gp39-specific mAb were able to block 
the activation of B cells by these plasma membranes (5). Re- 
cently, several groups (8-11) showed that mutations in gp39 
are responsible for the defective antibody production in pa- 
tients with X-linked hyper-IgM syndrome, indicating that 
this molecule expressed by activated Th cells is essential for 
humoral immunity. Isolation of cDNA clones encoding mu- 
fine (4) and human gp39 (12) showed that this molecule en- 
codes a type II membrane protein. Comparison of the predicted 
gp39 amino acid sequence with those of other published pro- 
tein sequences  shows that gp39 is homologous to TNF-a 
and -~ (12, 13). 
After the initial B cell activation by gp39, Th cell-derived 
cytokines regulate the differentiation of B cells into antibody- 
forming B cells (6, 7). The pattern of cytokine secretion by 
Th cells has been suggested to be decisive in the selection 
of isotype produced by ankibody-forming B cells (14-16).  It 
has been shown in vitro that Thl cells (17), which secrete 
IL-2 and IFN-'y, promote IgM and IgG2a secretion by B cells, 
whereas Th2 cells (IL-4 and IL-5) stimulate B cells to pro- 
duce antibodies of IgG1 and IgE isotypes (14-16). The puta- 
tive central role of gp39 and cytokines in the initiation and 
development of humoral immunity  is mainly based on in vitro 
studies. To date, no data has been presented about the simul- 
taneous expression of gp39 and cytokines during in vivo an- 
tibody responses.  Furthermore, the role of gp39 in in vivo 
antibody responses has not been addressed. A companion paper 
by Foy et al. (18) demonstrates that gp39 is essential for the 
induction of in vivo antibody responses  against various TD 
antigens. This study describes the in vivo development and 
localization of gp39 + cells and cytokine-producing cells in 
relation to antigen-specific antibody formation. 
Materials and Methods 
Animals.  BCBA.Fx  (C57BL  ￿  CBA) mice were bred at the 
TNO breeding facilities  (Rijswijk, The Netherlands). Animals  were 
used at 16-24 wk of age and were kept under a standard protocol 
with flee access to pelleted food and acidified water (pH 3). Ex- 
periments were performed under the auspices of the Dutch Veteri- 
nary Inspection, as described in the law on animal experiments. 
Chemicals.  Alkaline  (AP; P-6774, type VII-T, 1,020 U/mg pro- 
tein), 3-amino-9-ethylcarbazole  (AEC; A5754), CFA, 3,3-diamino- 
benzidine-tetrahydrochloride, Fast blue BB Base, Fast red, horse- 
radish peroxidase (HKP), IFA levamisole, and naphthol AS-MX 
phosphate (3-hydroxy-2-naphtoic  acid  2,4-dimethyl-anilide  were ob- 
tained from Sigma  Chemical  Co. (St. Louis,  MO) N-hydroxysuccini- 
midyl-(biotinamido)-hexanoate  and maleimidohexanoyl-n-hydroxy- 
succinimide  ester were obtained from Pierce (Rockford, IL). B-Gal 
(Escherichia coli derived /3-n-Gal galactohydrolase, 540,000), and 
X-Gal (5-bromo-4-chloro-3-indolyl-B-D-galactopyranoside)  were ob- 
tained from Boehringer Mannheim (Mannheim, FRG). 
Reagents.  TNP-Ficoll and TNP-KLH were prepared as previ- 
ously described (19, 20). The  rat  mAb  Lyt2  +  (CD8)  (clone 
53.6.7.2) (21) and L3T4 (CD4) (clone GK-1.5) (22) were used as 
cell markers. The control hamster antibodies and ascites from the 
cell lines MK1 (5), a mAb directed to gp39 and KG7, a mAb specific 
for rat/hamster Igg (KG-7; 23) chain were purified by means of 
a protein A column. Anti-human IgG1 (3.1.1; 24) and human IgG1 
were obtained from Nordic Immunological Labs (Tilburg, The 
Netherlands). The routine mAb DB-1 directed to IFN-% was a 
kind gift of Dr. P. H. van der Meide (25) from our Institute. The 
cells of the rat mAb 11Bll, directed to IL-4, and II.-4 were a kind 
gift of  Dr. W. E. Paul (Laboratory of Immunology, National Insti- 
tute of Allergy and Infectious Diseases, National Institutes  of 
Health, Bethesda, MD [26]). The IL2-specific mAb, $4B6, was 
a kind gift of Dr. T. Mosmann (17). Control rat mAbs (2A4, 1Gll) 
were a kind gift of Dr. A. Zantema (Sylvius Laboratory, Leiden, 
The Netherlands [27]). Recombinant mouse IL-2  was obtained  from 
Genzyme Corp. (Cambridge, MA). The X6310 cell  lines producing 
II.,4 or IL-2 were a kind gift of Dr. F. Melchers (Basel Institute 
of Immunology, Basel, Switzerland [28]). Antibodies were purified 
from culture supernatants using an affinity chromatography goat 
anti-rat Ig column. Cytokine-specific,  gp39-specific, and control 
antibodies were conjugated to AP and HRP, as previously  described 
(29). Conjugation to 3-Gal was performed according to the proce- 
dure described  by Deelder and De Water (30) with minor modifica- 
tions (31). TNP-AP and KLH-HRP were prepared according to 
the previously described methods (19, 20). 
Experimental  Design.  BCBA.F1 mice were injected intrave- 
nously with 100 #g of KLH or TNP-KLH,  or 20 #g of TNP- 
Ficoll and killed after 0, 1, 2, 3, 4, 5, 6, and 7 d. Another group 
of mice was injected with 100 #g of KLH, boosted 16 wk later 
with 100 #g TNP-KLH, and killed after 0, 1, 2, 3, 4, 5, and 7 
d. In a parallel experiment, mice  were immunized subcutaneously 
with TNP-KLH in CFA, boosted 4 w later subcutaneously with 
20 #g TNP-KLH in IFA, and killed 6 d after injection. Spleens 
and draining popliteal lymph nodes were removed, immediately 
frozen in liquid nitrogen,  and stored at  -70~ 
Imraunohistochemistry.  Splenic  cryostat sections (- 20~  8 #m), 
one of every mouse, were picked up on the same glass slide and 
kept overnight under high humidity at room temperature. Slides 
were air-dried and stored in airtight boxes until use. Slides were 
fixed for 10 min in acetone containing 0.02% H202. Slides were 
incubated horizontally overnight at 4~  with primary cytokine- 
specific, antibody conjugates diluted in PBS containing 0.1% BSA 
and titrated to obtain optimal results. Immunohistochemical  demon- 
stration of gp39 was performed in two ways: first, with a gp39- 
specific hamster mAb, MR-l, followed by a hamster Ig-specific 
mAb, KG-7, conjugated to peroxidase; second, with a fusion pro- 
tein of the gp39 receptor, CD40-IgG1 (5), followed by a human 
IgGl-specific mAb conjugated to peroxidase. For double staining 
of gp39 and CD4 or CDS, spleen sections were incubated simul- 
taneously with MK-1-AP and L3T4-HKP or Lyt2  +-HKP. Detec- 
tion of KLH-specific  antibody-forming  cells (KLH-AFC)  and TNP- 
AFC were detected according to previously  described methods (19, 
20). Slides were washed with PBS (three times for 5 min) and im- 
munohistochemical revelation was performed as described previ- 
ously; AP (29), HRP (29), and fl-Gal (30). For double staining, 
the immunohistochemical revelation of AP was performed before 
HKP, and the B'gal staining before AP or HKP, because both the 
peroxidase substrate and the AP substrate were found to inhibit 
the/3-gal  activity. To ensure that no over- or understaining oc- 
curred, slides with adherent substrate solution were monitored by 
light microscopy  during histochemical  reactions. Sections  were  coun- 
terstained with hematoxylin  and mounted in glycerin  gelatin. AFC, 
gp39 + cells, and cytokine-producing cells (PC) were counted, 
and image analysis  was performed as previously described (32). A 
minimum of three sections of each mouse were examined. 
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Gp39 Expression in Immune Spleen.  Spleen  sections from 
mice immunized with KLH were stained for the expression 
of gp39. Two gp39-specific reagents were used for detection: 
first, MR1, a gp39-specific mAb, and second, CD40-IgG1, 
a soluble, recombinant fusion protein of the gp39 receptor 
and IgG1. In serial spleen sections, CD40-IgG1 and anti-gp39 
identified the same number of cells, which were localized in 
identical  anatomical  locations  (Fig.  1, A  and B;  Table 1). 
Moreover, MR1 blocked the staining with CD40-IgG1 in 
a dose-dependent manner, confirming the fact that MR1 and 
CD40-IgG1 recognize the same molecule, gp39 (5). Immuno- 
histochemical double staining, using anti-gp39 and anti-CD4 
mAb, showed that gp39 expression was restricted to the CD4 
lineage cells (Fig.  1 C). 
Localization and Kinetics of  gp39 + Cells in Lymphoid Tissue. 
Gp39 + Th cells were found predominantly in the outer- 
periarteriolar lymphocyte sheaths (PALS) and around the ter- 
minal arterioles (TA) of the spleen (Table 1,  Figs. 1/1  and 
2B). Double staining  for CD4 + and gp39 clearly revealed 
that CD4 + cells in primary follicles were not gp39 positive 
(Fig.  1  C).  After  secondary  immunization,  only a  few 
gp39 + cells were observed in the follicular corona, but not 
in the germinal centers (GC) of secondary follicles (Fig. 1 
A). Examination of lymph node sections of TNP-KLH im- 
munized mice revealed that gp39 § cells were localized in the 
deep cortex and along the medullary cords (Fig.  1 B). In- 
cidentally, gp39 § cells were observed in the corona, but not 
in the GC, of follicles in lymph nodes (data not shown). At 
day 3 and 4 after injection of KLH, we observed the max- 
imum  number  of gp39 §  cells (Fig. 3).  Thereafter,  the 
number decreased and remained stable during the next 3 d. 
Another group of mice was boosted 16 wk later with KLH. 
Already during the first 2 d after secondary immunization 
we observed  a striking increase in the number of gp39 + 
cells, which was markedly higher as compared to the pri- 
mary response. After 4 d, the gp39 + cells reached maximum 
numbers, which were about two times higher as we observed 
during the primary immune response against KLH (Fig. 3). 
Immunization with TNP-Ficoll,  a thymus-independent  type 
2 (TI-2) antigen, resulted in an increase in the frequency of 
gp39 + Th cells, attaining maximum frequencies 5 d after in- 
jection (Fig. 4).  As was observed for TD antigens,  in the 
antibody response  against  TNP-Ficoll,  gp39 +  cells were 
localized in the outer-PALS and around the TA of the spleen 
(Fig. 2 B). No gp39 expression was observed in the splenic 
follicles of mice immunized with TNP-Ficoll. 
Localization and Kinetics of Cytokine-producing Cells in the 
Spleen.  Th cell-derived cytokines have a decisive role in iso- 
type selection (14-16). As antibody responses against TNP- 
KLH  are dominated by IgG1  antibodies,  we investigated 
whether a Th subset (Thl/Th2) was preferentially activated 
and where these cytokine-PC were localized in the spleen. 
Detection of cytokine-PC was performed with cytokine- 
specific mAb conjugated to  different  enzymes on splenic 
cryostat  sections of TNP-KLH immunized mice. The IL- 
4-specific mAb (11Bll) conjugated to B-gal was used for the 
in situ demonstration of IL-4-PC. After immunohistochem- 
ical revelation, IL-4-PC characterized  by a turquoise cytoplasm 
were detected (Fig. 1 D). No staining was observed in con- 
trol slides from any specimen treated by omission or substi- 
tution of the primary antibody. Preincubation of 11Bll con- 
jugated to fl-gal with recombinant IL-4 inhibited the staining 
of IL-4-PC,  in  a dose-dependent  manner.  Moreover,  the 
specificity of the staining was confirmed on cytospin prepa- 
rations of cells from an IL-4-producing cell line (X6310-IL- 
4). IL-2-PC were demonstrated with an IL-2-specific mAb 
($4B6) conjugated to HRP and were characterized by a red- 
stained cytoplasm, respectively (data not shown). Control im- 
munoconjugates showed no staining. Furthermore, the specific 
staining was inhibited by recombinant IL-2 in a dose-dependent 
manner. In addition,  specificity was confirmed on cytospin 
preparations of  cells from an IL-2-producing cell line (X6310- 
IL-2). The specific  demonstration of IFN-7-PC, with an IFN- 
7-specific mAb (DB-1) conjugated to alkaline phosphatase, 
was performed as described previously (32, 33). In all spleen 
sections examined, cytokine-PC were observed in the outer- 
PALS and around the TA of the spleen. Cytokine-PC were 
never observed in the follicles or marginal zone of the spleen. 
Analysis of the kinetics of cytokine-PC revealed higher fre- 
quencies of IL-2-PC and IL-4-PC, relative to IFN-3'-PC,  in 
the antibody response against TNP-KLH, reaching maximum 
frequencies at 3-4 d  after immunization (Fig. 5). 
Cytokine Production by gp39 + Cells.  Gp39 + cells are a 
prerequisite for B cell activation in vitro (5) and TD anti- 
body responses in vivo (18). Thereafter, cytokine-producing 
Th cells are thought to be active as regulators of antibody 
responses. To investigate whether gp39 + cells have the ca- 
pacity to produce cytokines, as was suggested by in vitro ex- 
periments (34), we performed double-staining  experiments. 
MR-1 (gp39) was conjugated to AP, whereas $4B6 (IL-2) 
and 11Bll (IL-4) were conjugated to HRP and fl-Gal, respec- 
tively. Double staining for IFN-7 and gp39 was performed 
with a direct IFN-7-specific conjugate and MR-1 followed 
by a secondary HRP-conjugated mAb directed to hamster 
Ig. Double staining for IL-2 and gp39 revealed red-stained 
cells producing IL-2,  blue-stained  gp39 + cells, and violet 
double-staining  cells, representing gp39 *  cells producing 
IL-2 (data not shown). In the case of IL-4 and gp39,  the 
turquoise-stained cells were IL-4-PC and the red-stained cells 
were  gp39 +,  whereas  double-staining  violet  cells were 
gp39 + cells producing IL-4 (Fig. 1 D). After double staining 
for IFN-7 and gp39,  we observed blue-stained IFN-7-PC, 
red-stained  gp39 +  cells, and  double-staining  violet  cells, 
representing  gp39 +  cells  producing  IFN-7  (data  not 
shown). In the spleen, gp39 + cells producing IL-2, IL-4, or 
IFN-7 were found both during TD and as TI-2 antibody 
responses. 
Kinetics and Localization of Antigen-specific AFC.  Using 
KLH-HRP and TNP-AP conjugates, we were able to study 
the development of KLH-AFC and TNP-AFC in the spleen 
after immunization with KLH or TNP-KLH (35). As demon- 
strated in Figs. 3 and 4, in both experiments the kinetics of 
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cells are colocalizing in the immune spleen. (.4) 
4 d after secondary KLH immunization, KLH- 
AFC, stained red, were found in close proximity 
to gp39 + cells, stained blue (KLH-HILP, AEC; 
MR1-AP, Fast blue). (B) 5 d after TNP-Ficoll im- 
munization, Gp39 + cells, stained red, and TNP- 
AFC, stained blue, are found in the same compart- 
ments.  Note the gp39 + cells in dose proximity 
to TNP-AFC in outer-PALS and around TA, but 
not in follicles and marginal zone. Immune com- 
plexes are found in the follicles  (TNP-AP, Fast blue; 
MR1  +  RG7-HRP, AEC). (c) Central arteriole, 
follicle, (ra) marginal zone, (o) outer-PALS, (r) 
red pulp,  (t) lymphocyte sheath around terminal 
arteriole. 
Figure  1.  Immunohistochemical  localization and characterization of gp39 + cells  in lymphoid organs. Cryostat  sections of murine lymphoid tissue 
were incubated with specific immunoconjugates, foUowed  by immunohistochemical  revelation. Conjugates and substrates used are indicated between 
parentheses. (A) 4 d after secondary intravenous immunization with KLH; red stained cans are gp39 + cells localized in outer-PALS (o), around the 
TA (t), and in the follicle 0~ of the spleen (MR1  +  KGT-HR.P; AEC). (B) Cryostat section of lymph node 6 d after secondary subcutaneous immuniza- 
tion with TNP-KLH; red stained cells are gp39 + calls localized in the deep cortex and alon the medullary cords. In this section, no gp39 + cells are 
localized in the follicle (]) (MR1  §  RGT-HRP; AEC). (C) 3 d after KLH immunization; red membrane positive cells are CD4 § cells, whereas violet 
double-staining  cells are CD4 + cells expressing gp39 (arrow). Note that CD4 + calls are present in the follicle ~, whereas CD4 + cells  expressing gp39 
are found around TA (t) and not in the primary follicle (~ (L3T4-HRP, AEC; MR1-AP, Fast blue). (D) 4 d after KLH immunization, red stained 
cells are gp39 +cens, turquoise stained calls are IL-4-PC, whereas violet stained cells are gp39 + cans producing IL-4 (arrows). (MR1-AP, Fast red; 11Bll- 
15-Gal, X-Gal). 
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White pulp 
Immunization  Day  Reagent  Fc  GC  iP  oP  MZ  TA  Red pulp 
Saline  4  MR-l*  0*  0  0  2  +  2  0  7  •  5  0 
TNP-KLH:  primary  4  CD40-Ig  0  0  0  16  +  7  0  115  _+  16  0 
4  MR-1  0  0  0  20  +  5  0  106  _+  30  0 
TNP-KLH:  secondary  4  MR-1  1  _+  1  0  0  36  +  12  0  165  _+  19  0 
TNP-Ficoll: primary  5  MR-1  0  0  0  60  +  18  0  222  +  30  0 
Mice were immunized and killed  on the indicated  day. 
*  Cryostat sections were prepared  from spleens and immunohistochemical demonstration of gp39 was performed with an anti-gp39  mAb, or with 
CD40-Ig followed by secondary peroxidase conjugates.  Cells were counted in each anatomical  compartment of the spleen: Fc, follicular corona;  iP, 
inner-PALS;  oP, outer-PALS;  MZ, marginal  zone. 
* Values represent  mean  _+  SD number of positive  cells in each compartment  of spleen sections from three mice. 
KLH-AFC or TNP-AFC developed according to similar pat- 
terns attaining maximum frequencies at 4 d after immuniza- 
tion. The frequency of TNP-(hapten)-specific AFC was about 
10 times higher than the detected frequency of AFC specific 
for the carrier (KLH). After boosting with KLH we found 
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Figure  3.  Kinetics of gp39 + T cells and KLH-AFC after primary and 
secondary immunization with KLH. BCBA.F1 mice were injected intra- 
venously with 100/~g KLH (19) and killed at the indicated time points. 
Another group of BCBA.F1 mice was injected  with 100/~g of KLH, 
boosted  16 wk later with 100/~g KLH i.v. and killed at  the indicated 
time points. Spleens were removed and immunohistochemistry and image 
analysis were performed as described in Materials  and Methods.  Values 
represent  mean  _+  SD of number of positive cells per mm  2 from three 
mice.  (A) KLH-AFC; (0)  gp39-bearing  cells. 
"~8-10 times more KLH-AFC as compared with the primary 
immunization  at the peak of the response (Fig. 3). Immuni- 
zation with TNP-FicoU resulted in a gradual increase of the 
number of TNP-AFC attaining  the maximum number at 
day 5 after immunization  (Fig. 4). 
Gp39 + Cells Colocalize with Antigen-specific B  Cells.  As 
gp39 + Th cells have been found to be essential for the acti- 
vation of B cells in vitro and in vivo, their anatomical local- 
ization in relation to resting and antibody-producing B cells 
was  examined. Double immunohistochemical  staining  for 
resting B cells (membrane IgM-bearing) or B plasma blasts 
(cytoplasmic  Ig)  and  gp39,  revealed that  the majority  of 
gp39 § Th cells were codistributed among both B cell types 
in the outer-PALS and TA (data not shown).  In addition, 
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Figure 4.  Kinetics of gp39 + cells and TNP-AFC may be superimposed 
after immunization with TNP-Ficoll. BCBA.F1 mice were injected intra- 
venously with 20 #g TNP-Ficoll and killed at the indicated time points. 
Spleens were removed and immunohistochemistry  and image analysis were 
performed as described in Materials and Methods.  Values represent mean 
_+  SD of number of positive cells per mm  2 from three mice. (ll) TNP- 
AFC; (Q) gp39-bearing  cells. 
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Figure 5.  Cytokine PC and TNP-AFC develop  according to similar 
kinetics after immunization with TNP-KLH.  BCBA.F1  mice were in- 
jected intravenously with 100 #g TNP-KLH (19) and killed at the indi- 
cated time points. Spleens were removed and immunohistochemical demon- 
stration of IL-2-, IL-4-,  IFN-3'-PC,  and TNP-AFC were performed as 
described in Materials and Methods. Values represent mean _+ SD of number 
of positive cells per mm  2 from three mice. 
when antibody-forming B cells, specific for the immunizing 
antigen,  were  revealed,  the  KLH-AFC/TNP-AFC  were 
found in close proximity to the gp39 § Th cells (Fig. 2 A). 
Also in the immune response against  TNP-FicoU  we ob- 
served antigen-specific B cells (TNP-AFC) colocalizing with 
gp39 + cells in the outer-PALS and around the TA (Fig. 2 B). 
Discussion 
The present study demonstrates that during in vivo anti- 
body responses gp39 expression and cytokine production de- 
velop simultaneously and are predominantly localized in the 
outer-PALS and around the TA of the spleen. The gp39 + 
cells and cytokine-PC are found in close proximity to antigen- 
specific B ceils. These results suggest that the initial Th cell 
induced B call activation and the subsequent Th ceil regu- 
lated B cell differentiation occur in restricted compartments 
of the spleen. Furthermore, high frequencies of IL-4-PC, rd- 
ative to IFN-y-PC, are found in the immune response against 
TNP-KLH. 
In the primary antibody response against KLH, maximum 
frequencies of gp39 § Th ceils were observed 3-4 d after in- 
travenous immunization (Fig. 3). Later, during the course 
of the immune response, reduced numbers of gp39 + Th ceils 
were present. ParaUd studies using KLH-primed mice showed 
that upon secondary immunization with KLH, a significant 
increase in gp39 + Th ceils was observed within 24 h (Fig. 
3).  Maximum frequencies in the secondary response were 
reached at day 4 and were about twice as high as those ob- 
served during primary responses. This observation is in agree- 
ment with the results described in the accompanying paper 
(18), which shows a twofold increase in helper activity after 
adoptive transfer of SRBC-immunized spleen cells. Further- 
more,  the kinetics  of appearance of gp39 §  Th cells and 
KLH-AFC were superimposable  (Fig. 3). In vitro studies using 
Th cell dories have demonstrated that gp39 is rapidly expressed 
upon triggering with anti-CD3 mAb (5). Data presented 
herein document that in vivo administration of antigen in- 
duces a rapid expression of gp39  on CD4 § Th cells. The 
simultaneous  development  of gp39 + calls and KLH-AFC, 
together with the demonstration of gp39 § Th calls in close 
proximity to KLH-AFC, suggest that gp39 expression plays 
a role in the specific antibody production. This is substan- 
tiated by experiments described in the accompanying paper 
(18) which show that anti-gp39 mAb were able to significantly 
reduce the antibody responses to KLH in vivo. 
It is well known that rigorous T cell depletion completely 
abrogates the anti-TI-2 antibody response, indicating that 
T ceils are necessary for a bona fide TI-2 response (36-38). 
The observed high frequency of gp39 § Th cells after immu- 
nization with TNP-Ficoil was surprising, given the fact that 
the antibody responses to TNP-Ficoil were unaffected in vivo 
after administration of  anti-gp39 mAb (18). This finding shows 
that gp39 expression on T cells in the spleen by itself is not 
enough to activate B ceils or could indicate that gp39 de- 
tected in the spleen sections is not the same gp39 that seems 
to be necessary for TD antibody responses in vivo. The pro- 
cess of T  cell activation,  revealed in vivo as an increase in 
the number of gp39 + Th ceils, could be explained as sug- 
gested by DeKruyff et al. (39), who showed in vitro that 
in TI-2 immune responses, activated B ceils were responsible 
for the activation of T ceils. Similar results were described 
by Zisman et al. (40), who demonstrated that TI-2 antigens, 
composed of D amino acids which bind to class II molecules 
of APCs, were able to activate T cells. These activated T ceils 
can produce cytokines, as was demonstrated in vitro (40) and 
in vivo (32), and may regulate the proliferation and differen- 
tiation of B ceils activated by TI-2 antigens  (41). 
Analysis of the kinetics of cytokine-PC revealed that IL-2- 
PC and IL-4-PC were predominant in the antibody response 
against KLH with maximum frequencies at 3-4 d after im- 
munization. The IFN-3,-PC were also found to be active in 
this immune response, reaching maximum levels at day 3, 
but the number of IFN-~/-PC was low as compared with 
the number of IL-2-PC and IL-4-PC. Bradley et al. (42) ob- 
served that  the kinetics  of appearance of effector CD4 + 
T ceils that produce cytokines upon restimulation with KLH 
in vitro were similar for each of the cytokines investigated. 
These results confirm our in vivo findings and suggest that 
after immunization and subsequent antigen presentation,  T 
cells with potency to produce IL-2, and/or IL-4, IL-5 and/or 
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into cytokine-PC, following a similar time course.  At the 
peak of the immune response,  we observed relatively high 
frequencies of IL-2-PC and IL-4-PC in the outer-PALS and 
around the TA. As these cytokine-PC were observed in close 
conjunction, it is likely that these cells create a microenviron- 
merit which is rich in IL-2 and IL-4. Such a microenviron- 
ment has been suggested to be essential for the development 
IL-4-PC, as was demonstrated in vitro (43-45).  These ex- 
periments suggested that IL-2 was required for the optimum 
proliferation of cytokine-producing  T cells (43-46), whereas 
IL-4 would propagate the preferential development of IL-4- 
PC (43, 44).  After double staining, we were able to detect 
TNP-AFC  in  dose  proximity to  cytokine-PC (data  not 
shown), suggesting that these cytokines have a role in B cell 
differentiation. Nossal and Riedel (47), demonstrated a rapid 
rise in precursors of KLH-binding IgGl-secreting B cells in 
the spleen 5-7 d after KLH immunization. IL-4 has been 
suggested to play a role in B cell switching to IgG1 and in 
the propagation of IgG1 + AFC  (16). Consequently, the 
close proximity of IL-4-PC to KLH-specific B cells may stimu- 
late the preferential  development of IgG1 + B cells. 
In this study we observed incidently (<1%) gp39 + cells 
in the corona of the follicles, but no gp39 + cells or cytokine- 
producing T cells were found in the GC. These observations 
are compatible with studies in humans (48-50) and mice (32, 
51), which demonstrated that none of the B cell differentia- 
tion factors,  such as IL-2, IL-4, and IFN-% were localized 
in the follides of lymphoid tissue. Butch et al. (52) showed 
in vitro that IL-4 mRNA was the only cytokine expressed 
by GC T cells, whereas these T cells expressed no mRNA 
of the other nine tested cytokines. As this group examined 
cytokine mRNA expression in vitro, which is not always 
correlated with protein synthesis in vivo (53), these data are 
not incompatible with our in vivo results. 
Recently, Lederman et al. (54) demonstrated in human lym- 
phoid tissue that the T-B cell activating molecule (T-BAM), 
the human equivalent of gp39, was expressed on CD4 + cells 
in the PALS of the spleen and in lymphoid follicles of tonsils, 
lymph nodes, and spleens. Essentially  the human and mu- 
fine studies give identical localization patterns for gp39 ex- 
pressing T cells. The observed difference in the number of 
positive cells in the follicles is most likely due to the fact that 
the murine studies are performed with a nonreplicating an- 
tigen, whereas the human material is most probably chron- 
ical inflamed (more activated  T  cells). 
During primary immune responses, antibody production 
in PALS and around TA precedes the GC formation, indi- 
cating that the initial B cell activation occurs outside the fol- 
licles (55-57). This is in agreement with the results presented 
in this report, showing no gp39 § cells or cytokine-PC in 
the follicles, but in the outer-PALS and around the TA. Only 
after  secondary immunization, did we observe  a low fre- 
quency of gp39 + cells in the corona of lymphoid follicles. 
The similar localization  of AFC (35), gp39 + cells, and cyto- 
kine-PC as observed in the immune response against KLH 
or TNP-Ficoll, suggests that T-B cell interactions during pri- 
mary and secondary antibody response against TD or TI-2 
antigens occur in the same splenic compartments, e.g., the 
outer-PALS  and TA.  Furthermore, it validates in vitro ex- 
periments demonstrating that the kinetics of cytokine produc- 
tion and CD40-1igand expression can be superimposed (7). 
The observation that during the entire experimental period 
antigen-specific  AFC and gp39 § cells were found in close 
proximity, in addition to in vitro experiments which showed 
that extended contact (more than 48 h) is required for max- 
imal proliferative responses (58) or cytokine production (59), 
suggests that T-B conjugates may persist for several days in 
vivo. 
Fig. 6 shows a model for the development of TD antibody 
responses in the spleen based on presented data and on the 
localization and migration of immune cells (51). We suggest 
that during the primary antibody response, TD antigens are 
presented by interdigitating cells in the PALS, leading to in- 
creasing  numbers of antigen-specific  T  cells which subse- 
quently encounter antigen-specific  B cells in the PALS, forming 
T-B cell conjugates (60, 61). During this cognate T-B cell 
interaction,  CD4 + Th cells will be activated  by antigen- 
presenting B cells and express the ligand for CD40.  Gp39 
will trigger B cell growth and differentiation. Part  of the 
activated B cells migrates to the follicles to undergo follic- 
ular processes, such as B cell selection,  somatic mutation, 
affinity  maturation, and memory formation (55,  56).  An- 
Figure 6.  Schematic representation of the activation and migration of 
T  and B cells in the spleen during the TD immune response.  (Amavs) 
Migration orB and T cells in the spleen. (C) Central arteriole., (F) follicle, 
(Fc) follicle corona, (MZ) marginal zone, (/P) inner-PALS, (oP) out~-PALS, 
(RP) red pulp, (TA)  lymphocyte sheath around terminal arteriole.  (Q) an- 
tigen, (  ~  ) resting B cell, ( ~iJ  ) memory B cell,  (  ~t  ) differen- 
tiating antigen-specific  B cell, (1~  ) antibody-forming B cell, (  O  ) 
resting T cell, ((D~)  activated antigen-specific  T cell (~p39+), (  ~  ) 
cytokine-producing T  cell,  (  llr  ) FDC,  (  "~  ) IDC. 
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differentiates into antigen-specific AFC regulated by activated 
cytokine-producing T cells. After secondary immunization, 
antigen-specific memory B cells acquire the antigen in the 
follicle, where it is presented by follicular dendritic cells in 
the form of immune complexes (55, 56). These B cells will 
migrate to the PALS and meet antigen-specific T  cells and 
will subsequently follow the pathway as described for pri- 
mary immune responses. In case of secondary TD antibody 
responses, the follicles already contain relatively high frequen- 
cies of antigen-specific B cells, which increases the likelihood 
that B cells encounter antigen-specific T  cells in the PALS. 
This may explain the relatively high frequency of activated 
gp39 + T  cells and antigen-specific AFC found during  sec- 
ondary immune responses. The observation of high frequen- 
cies of antigen-specific AFC relative to gp39 § T  cells (Fig. 
3), suggests that one T cell may be able to activate more than 
one B cell.  Alternatively,  the relatively low frequencies of 
gp39 + T ceils could be due to the shorter lasting expression 
of gp39 by T  cells (7, 62) as compared with the expression 
of antigen-specific antibodies by B  ceils. 
In conclusion, this study demonstrates that gp39 + T cells 
and cytokine-PC are simultaneously upregulated in vivo after 
immunization.  These gp39 + cells and IL-4-PC are observed 
in  dose  proximity  to  antigen-specific  B  cells.  The  data 
presented suggest that  the initial cognate B ceil activation 
and the subsequent regulation of B cell differentiation by T 
cells occur in the nonfollicular areas  of the spleen, namely 
the outer-PALS and around  the TA. 
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